"If a major pharma were observing ___ ___’s work I doubt they’d be telling us about it."
That's true. And it has been true for years no matter how you would have filled in that blank. My comment wasn't restricted to the most recent lack of reported interest:
"There is no evidence that Brilacidin has drawn any interest from a major pharmaceutical firm, leaving in question whether it has in fact been shown to be "very safe with good test results". For the most part, SO FAR, those who believe that to be true reside here and the strength of their conviction can be measured by the share price."
The number of times that we have been told of some interest is precisely equal to the amount of times that we've been told that no details could possibly be revealed. We do know, however, how many deals have been struck as a result of all of that interest.
I did watch the presentation btw and IIRC there was some background chortling in response to "When talking about testing a drug combo Dr Goldman mentioned the test mice being “unhappy” for awhile and later said “they didn’t die” in a positive tone."
I think he even smiled a little when he said it. I guess a lack of death is a pretty good measure of safety :o)
"He also mentioned that if needed they felt the B dosage could be increased."
He did mention that for one indication....after he indicated that they had reached the safe dose in another.
News 
Market Data 
Discover 
